Medical Condition News

RSS

New study challenges long-held belief about how chemotherapy works

A new study from the University of Wisconsin–Madison suggests that chemotherapy may not be reaching its full potential, in part because researchers and doctors have long misunderstood how some of the most common cancer drugs actually ward off tumors.

26 Oct 2023

Study: Nearly 1.7 million people could be living with dementia in England and Wales by 2040

Up to 1.7 million people could be living with dementia in England and Wales by 2040 – over 40% more than previously forecast – finds a new UCL-led study.

26 Oct 2023

Can the planetary health diet save your life and the planet? Study finds mixed results

Adhering to a Planetary Health Diet (PHD), which emphasizes plant-based foods, was found to reduce risks of chronic diseases and death among Chinese Singaporeans, according to a new study. However, while higher PHD scores were linked to a 7% reduction in greenhouse gas emissions, they also resulted in increased land and water usage

26 Oct 2023

Groundbreaking research advances understanding of how pathogens impact cancer

Viral infections are known to be a central cause of more than 10% of cancers worldwide. University of California researchers may have uncovered one of the key reasons why.

26 Oct 2023

Autistic people less likely to be affected by bystander effect in workplace, study finds

A well-established psychological theory states that most of us are less likely to intervene in a bad situation if other people are present, and this 'bystander effect' also applies to workplace settings.

26 Oct 2023

Endometriosis and irritable bowel syndrome share genetic risk factors, UQ research shows

University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other.

26 Oct 2023

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

A team of scientists led by KOO Sagang from the Seoul National University and Center for Nanoparticle Research within the Institue for Basic Science Center (IBS), in collaboration with researchers from Korea Institute of Science and Technology (KIST) and the Seoul National University, developed a new solution for the treatment of rheumatoid arthritis (RA).

26 Oct 2023

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Psoriasis - a chronic skin condition - is not caused or spread by spontaneous genetic mutations in the skin, new research suggests.

26 Oct 2023

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

A groundbreaking clinical trial launched October 16 will explore the promise of new drug treatments for military personnel and veterans suffering from post-traumatic stress disorder (PTSD).

26 Oct 2023

Researchers to develop machine models to predict cardiometabolic risks in young people

A researcher at Binghamton University, State University of New York will lead a $2.5 million project from the National Institutes of Health to develop machine models to identify and predict cardiometabolic risks in adolescents and young adults.

26 Oct 2023

Newly identified amino acid may play key role in predicting outcomes and treatment of long COVID

University of Alberta researchers have identified an amino acid that may play a key role in predicting poor clinical outcomes and the treatment of long COVID.

26 Oct 2023

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

26 Oct 2023

Genomic screening encourages people with hemochromatosis to seek treatment and relevant management

Genomic screening to identify hemochromatosis - a disorder that causes iron levels in the body to rise to dangerous levels - encourages people with the condition to seek treatment and ongoing management, a Geisinger study found.

26 Oct 2023

Study suggests heightened distractibility as a core ADHD deficit

Distraction is prevalent in our daily lives. As you read this, you might be distracted by external stimulations like people talking near you or a smartphone notification.

26 Oct 2023

Immunologists aim to explore new avenues for immunotherapy of liver metastases

Four distinguished immunologists have been awarded one of the most generously funded research grants from the EU: the ERC Synergy Grant.

26 Oct 2023

Treatment in ambulance-based mobile stroke unit increases the likelihood of averting strokes

Receiving a clot-busting drug in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and complete recovery compared with standard hospital emergency care, according to researchers at Weill Cornell Medicine, NewYork-Presbyterian, UTHealth Houston, Memorial Hermann-Texas Medical Center and five other medical centers across the United States.

26 Oct 2023

New bioreactor could accelerate access to cancer-killing immunotherapy

A new tool to rapidly grow cancer-killing white blood cells could advance the availability of immunotherapy, a promising therapy which harnesses the power of the body's immune response to target cancer cells.

26 Oct 2023

Discovery of protein interaction could lead to new schizophrenia treatments

The discovery of a physical interaction between two proteins in brain cells that can be traced in mice to control of movement, anxiety and memory could one day open the door to development of new schizophrenia treatment strategies, researchers say.

26 Oct 2023

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Researchers at the Universities of Amsterdam and Leiden together with the Netherlands Cancer Institute (Amsterdam) and Oncode Institute (Utrecht) have received a €10.6 million ERC Synergy Grant to develop innovative therapeutic approaches to target glioblastoma, a deadly primary brain tumor for which no curing therapy is yet available.

26 Oct 2023

Doubts abound about a new Alzheimer’s blood test

For the first time, people worried about their risk of Alzheimer's disease can go online, order a blood test, and receive results in the privacy of their homes.

26 Oct 2023

Medical Condition News

New study challenges long-held belief about how chemotherapy works

Study: Nearly 1.7 million people could be living with dementia in England and Wales by 2040

Can the planetary health diet save your life and the planet? Study finds mixed results

Groundbreaking research advances understanding of how pathogens impact cancer

Autistic people less likely to be affected by bystander effect in workplace, study finds

Endometriosis and irritable bowel syndrome share genetic risk factors, UQ research shows

New nanoparticle-based system developed for comprehensive treatment of rheumatoid arthritis

Somatic mutations in the skin not responsible for the start or spread of psoriasis

Clinical trial launched to explore new drug treatments for military personnel and veterans with PTSD

Researchers to develop machine models to predict cardiometabolic risks in young people

Newly identified amino acid may play key role in predicting outcomes and treatment of long COVID

$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome

Genomic screening encourages people with hemochromatosis to seek treatment and relevant management

Study suggests heightened distractibility as a core ADHD deficit

Immunologists aim to explore new avenues for immunotherapy of liver metastases

Treatment in ambulance-based mobile stroke unit increases the likelihood of averting strokes

New bioreactor could accelerate access to cancer-killing immunotherapy

Discovery of protein interaction could lead to new schizophrenia treatments

Researchers receive €10.6 million to develop new therapeutic approaches to target glioblastoma

Doubts abound about a new Alzheimer’s blood test

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News